Status:
COMPLETED
Comparison of Endoscopic Injection of Conventional and Double Doses Cyanoacrylate for Gastric Variceal Hemorrhage
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Gastric Variceal Bleeding
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The recent practice guideline recommends endoscopic injection of cyanoacrylate (GVO) is the preferred method to treat acute gastric variceal bleeding. The rebleeding rate remains high following GVO.We...
Detailed Description
Although outcome of variceal hemorrhage has been improved in the last two decades, variceal hemorrhage is still the most serious complication of portal hypertension and chronic liver disease. Occurren...
Eligibility Criteria
Inclusion
- Patients with liver cirrhosis and/or hepatoma
- Aged 18 to 80, who had endoscopy-proven acute GVB
- Clinical signs of hematemesis, coffee ground vomitus, hematochezia, or melena
- Endoscopic signs of active bleeding from the GV
- Adherent blood clots, white nipple signs, or erosions on the GV
- The presence of distinct large GV with red-color signs and absence of EV and other bleeding sources
- Who or their legally authorized representatives gave informed consent
Exclusion
- Patients had previous endoscopic, surgical treatment or transjugular intrahepatic portosystemic shunt (TIPS) for GVB
- Had a terminal illness of any major organ system, such as heart failure, uremia, chronic pulmonary disease, or non-hepatic malignancy.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT00735358
Start Date
September 1 2005
End Date
October 1 2007
Last Update
October 6 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.